ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 226 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $288,868 | -26.9% | 6,235 | +50.3% | 0.02% | -32.3% |
| Q2 2021 | $395,000 | -31.2% | 4,148 | -17.8% | 0.03% | -43.6% |
| Q1 2021 | $574,000 | +1410.5% | 5,046 | +1728.3% | 0.06% | +1275.0% |
| Q4 2020 | $38,000 | -66.7% | 276 | -80.2% | 0.00% | -69.2% |
| Q3 2020 | $114,000 | 0.0% | 1,396 | -47.8% | 0.01% | +18.2% |
| Q4 2019 | $114,000 | +1800.0% | 2,673 | +2573.0% | 0.01% | +1000.0% |
| Q2 2019 | $6,000 | -90.5% | 100 | -90.3% | 0.00% | -83.3% |
| Q2 2017 | $63,000 | +26.0% | 1,030 | +37.3% | 0.01% | +20.0% |
| Q1 2017 | $50,000 | -74.0% | 750 | -72.3% | 0.01% | -76.2% |
| Q3 2016 | $192,000 | -46.8% | 2,707 | -63.4% | 0.02% | -44.7% |
| Q2 2016 | $361,000 | +1144.8% | 7,391 | +1465.9% | 0.04% | +442.9% |
| Q1 2015 | $29,000 | – | 472 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |